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BKCasion of splice variants and β-subunits of the BK channel (big conductance Ca2+-
activated K+ channel, Slo1, MaxiK, KCa1.1) in rat cerebral blood vessels, meninges, trigeminal ganglion among
other tissues. An α-subunit splice variant X1+24 was found expressed (RT-PCR) in nervous tissue only where
also the SS4+81 variant was dominating with little expression of the short form SS40. SS4+81 was present in
some cerebral vessels too. The SS2+174 variant (STREX) was found in both blood vessels and in nervous tissue.
In situ hybridization data supported the ﬁnding of SS4+81 and SS2+174 in vascular smooth muscle and
trigeminal ganglion. β-subunits β2 and β4 showed high expression in brain and trigeminal ganglion and
some in cerebral vessels while β1 showed highest expression in blood vessels. β3 was found only in testis
and possibly brain. A novel splice variant X2+92 was found, which generates a stop codon in the intracellular
C-terminal part of the protein. This variant appears non-functional as a homomer but may modulate the
function of other splice-variants when expressed in Xenopus oocytes. In conclusion a great number of splice
variant and β-subunit combinations likely exist, being differentially expressed among nervous and vascular
tissues.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionIn comparison to the large family of voltage-gated potassium
channels (N30), the group of calcium-activated potassium channels
only includes a handful of genes including the SK, IK and BK channels
[1,2]. Of these, the BK channel is expressed inmost tissues and shows a
unique high unitary conductance and combined activation by
intracellular calcium and depolarization, which implies an important
role for the channel as a regulator of cell membrane potential in
response to calcium signalling e.g. in smooth muscle cells [3,4] and in
neurons [5–7]. Although encoded by a single gene, the BK channel
appears in different functional forms due to alternative post-
transcriptional splicing of the mRNA [8–11] and to co-expression of
modulatory β-subunits, both affecting the gating properties of the
channel [10,12], its response to secondmessengers [13] and sensitivity
to pharmacological agents [14,15].
Inclusions of intron sequence in the mRNA transcript are the
prevalent type of BK channel splice variance, compared to deletion of
exons (Table 1). At least ten different splice sites in the vertebrate BK
channel α-subunit have been described (see Fig. 1) and further
variants can be predicted from GenBank data, including truncated3533 2525.
ll rights reserved.variants where the inserted intron sequence contains a stop codon
[11]. In brain tissue [10,16] and in the cochlea [17], different splice
variants are apparently expressed simultaneously indicating that
splice-variation has implications for the function of the ion channel. In
the cochlea, e.g., the spatial distribution of splice variants is suggested
to be involved in frequency tuning [17]. The functional implications of
the alternative splicing has been studied in some cases and include an
inverted response to cAMP, altered response to membrane tension
[13,18], hypoxia [19] and steroid hormones [20], impaired membrane
expression [21,22], altered response to modulation by β-subunits
[6,23] and changed activation kinetics and calcium sensitivity [24,25].
Although identiﬁed in various tissues, the tissue distribution of splice
variants has not yet been systematically investigated as array-based
expression studies do not discriminate between splice variants (e.g.
GNF SymAtlas, GEO). Also splice-speciﬁc antibodies have not been
developed.
TheBKβ-subunits are a groupof small two transmembrane-segment
peptides that affects the channel properties. Four such β-subunits are
known so far (β1–4) in addition to the identiﬁed intracellular Cavβ1 [26].
In general, they increase the Ca2+ and voltage sensitivity and slow the
activation of the BK channel and in addition the β2 and some splice
variants of the β3 induces N-terminal dependent “ball” inactivation
[27,28]. The β-subunits may also affect the surface expression of BK
channels and its acute response to steroid hormones [29,30]. The β1 has
Table 1
List of reported vertebrate BK channel splice variants found at different splice sites
Splice
site
Variation
a.a.
Tissue origin/reference
A +36 Extented N-terminal. Mouse, rat and human [11,43].
B +66 Extented N-terminal. Rat [11,43].
mK44 +44 Human myometrium [12].
SV1 +33 Rat myometrium [21].
X1 +8 Rat cochlea [44].
IsoC +3 Rat (AY330292.1).
X2 +31 Rat cochlea [17].
+14⁎ Rat superior sagittal sinus/dura mater (this study), (BB642344)
SS1 +4 Human hippocampus [52]; human brain [10]; chick hair cells
[23]; chick brain [53]; turtle cochlea [24].
+31 Turtle cochlea [24].
+40 Human brain [10].
−96 Rat and human corporal tissue [22].
H +24 Human (AK128392) [11].
SS2 +58/61
“STREX”
Rat chromafﬁn cells [43,54]; rat pituitary [55]; rat myometrium
[56]; rat pancreas and brain [43]; mouse brain [57]; chick hair
cells [23]; chick heart [58]; turtle and rat cochlea [17,24].
+63 Human glioma cells [59].
+29 “e22” Human brain [10]; rat skeletal muscle and breast [13];
rat cochlea [60].
+3 Human brain [10]; mouse [13].
+4⁎ Mouse [13].
O +41 Human (AB113575) [11].
SS3 +8 Human brain [10].
SS4 +27 “Slo27” Rat brain [25]; human brain [10]; chick hair cells [23];
rat cochlea [17].
SS5 +(8–61)⁎ Various C-terminal sequences in human, mouse, dog [43], and
rat [17].
Numbers denote insert sizes in amino acid residues. Deletion of sequence is indicated by
minus sign (−) and stop codon indicated by asterisk (⁎). The list is non-exhaustive with
respect to deletions and truncated variants (see review [11] for details).
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while scarcely expressed in brain and skeletal muscle [15,31]. An
essential role of its modulatory effect on BK function has been
highlighted in arterial smooth muscle in a mouse knock-out model [3].
β4 is widely expressed but seems to be most abundant in brain tissue
and absent in e.g. liver and pancreas [15]. Also β2 is expressed in brain
and in addition in heart, while it apparently is absent in aorta, colon,
lung, pancreas, bladder [15]. In one study, β3 has been detected in testis,
lung, brain and heart but is absent in skeletal muscle, kidney and colon
[32], while another study ﬁnds β3 in testis only [28].
The BK channel is an important determinator of arterial smooth
muscle tone as has been illustrated by the effect of the selective BK-
channel inhibitor iberiotoxin, which induces vasoconstriction [33] and
attenuates the vasodilatory response of CGRP (calcitonin gene related
peptide) [34], acetylcholine [35], NO donor glyceryltrinitrate [36] and
PGI2 [37]. The BK channel thus holds a potential as a possible target for
modulation of systemic blood-pressure or local vasomotor-responses
(e.g. during migraine or stroke), yet the widespread distribution of BK
channels may be a hindrance for a therapeutic strategy due to side
effects. An example is the tremorgenic action of the BK-inhibiting
mycotoxins paxilline and penitrem [38], which is likely induced by an
effect on neuronal ﬁring frequency [39].
The cerebral andmeningeal arteries and the trigeminal ganglion are
involved in the pathophysiology of migraine headache, which likely
includes cranial vasodilation and trigeminal nerve-activity in concert
[40]. BK channels are expected to be expressed in these tissues, andmay
be activated indirectly by NO [36] or CGRP (vascular BK channels) [34],
but the molecular composition of these channels in terms of splice
variants and β-subunit expression has not been speciﬁcally inves-
tigated. The aim of the current study is therefore to determine the
variants of the BK channels present in the involved tissues (cerebral
blood-vessels and trigeminal ganglion). We found that the cerebral
vascular and neuronal tissues differ in their expression of two BK splice
variants (SS4+81, X1+24) and three β-subunits (β1, β2 and β4) in
particular. Surprisingly, a novel apparently truncated BK isoform
(X2+92) was found in a preparation of the dura mater containing tissue
from the superior sagittal sinus.
2. Methods and materials
2.1. Tissue isolation
Male rats were euthanized with intra-peritoneal injection of
pentobarbital. After cessation of motor reﬂexes, the abdominal cavity
was opened. The vascular systemwas cleared of blood components by
infusion of Krebs-buffer (in mM; NaCl 119, NaHCO3 15, KCl 4.6, CaCl2
1.5, NaH2PO4 1.2, MgCl2 1.27, and glucose 5.5, pH 7.4) into the left heart
ventricle via a syringe needle and drained through an incision in the
liver. The perfusionwas continueduntil blood-vessels in the ear pinnae
and eye had become transparent. Inner organ tissues were isolated,
washed in Krebs-buffer and submerged in RNAlater® ﬁxative (Sigma-
Aldrich). For cranial tissues, the brain was exposed by removal of the
top of the skull from the vertebral foramen (foramen magnum) and
onward through occipital and parietal bones. The brain was removed
by gently lifting up the frontal lobe with a blunt spatula, and then
retracting it from the cranial cavity. Pieces of the dura mater were
scraped off the inside of the skull and samples of the pia mater were
peeled off the brain surface upon slight drying. Cerebral arteries
(basilar, middle cerebral, anterior cerebral and circle of Willis) were
dissected off the brain surface under a microscope. During removal of
the brain the trigeminal gangliawere separated from it andwere easily
isolated from the base of the cranial cavity. Samples used for RT-PCR
were rinsed in buffer and either transferred to RNAlater® or frozen on
dry ice. Samples in RNAlater® were temporarily stored at 5 °C for 24 h
before freezing. For in situ hybridization, tissues were ﬁxated in cold
formalin (10%) for 24 h and subsequently embedded in parafﬁn.2.2. RNA extraction
Total RNA was isolated from tissues with the RNeasy® Mini Kit
(QIAGEN). Samples were lysed andmechanically homogenized (Ultra-
Turrax). Solid material was cleared by centrifugation and the
supernatant was mixed with ethanol and added to RNeasy® mini
spin columns. After successive wash and on-column DNase treatment
(RNase-Free DNase Set, QIAGEN), the RNAwas eluted with RNase-free
water and stored at −80 °C. The integrity of the isolated RNA was
tested either on a Bioanalyzer RNA chip (Agilent Technologies) or by
agarose gel electrophoresis.
2.3. RT-PCR
Potential sites for BK channel transcript variation were found in
literature and by alignment of rat BK nucleotide sequences in the NCBI
database (Nucleotide). Primers were designed with Vector NTI
targeting the rat BK α-subunit (KCNMA1) and β-subunit (KCNMB1–
4) mRNA sequences retrieved from the nucleotide database (Table 2).
Identical Tm values and a G/C content of 40–60% were aimed for in
each primer pair (primer sequences and accession-number for
template-sequences are shown in Table 2). Speciﬁcity was tested by
running a combined BLAST search on both primer sequences. Primer
oligo-nucleotides were synthesized by MWG Biotech (Martinsried,
Germany).
Reverse-transcription (RT) PCR was performed with the QIAGEN
One-Step RT PCR kit combining Omniscript/Sensiscript reverse
transcriptase and HotStarTaq DNA polymerase, as described by the
manufacturer, except that reaction volume was reduced from 50 to 20
or 10 μl. Primers were used in a concentration of 0.6 μM as default. For
simultaneous ampliﬁcation of α- and β-subunits (multiplex), the
concentration of primers for the most dominating transcript was
reduced to 0.3 or 0.1 μM to avoid competitive repression, and to yield
similar band intensities.
Table 2
List of oligo-DNA primers and probes used in this study
PCR primers Accession Sense (forward) 5′–3′ Antisense (reverse) 5′–3′ bp
SV1 NM_031828 GCCAGGCAGATGGTACTCTCAA CAAGGGCACCAATGCTGAGA 171
X1 q TGACTGGCAGAGTCCTGGTTGTGTT GAAGAACACGTTGAAAGCCATGTCG 152
IsoC/X2 q TGGCTGACTGCAGCTGGATTC CCCGGTCCTTGTGCAGAAAGT 379
SS1 q CACAGAATATCTTTCCAGTGCCTTC ACCTTCTTGGGTCTTAAGGTGGTT 178
SS2 q TACTGCAAGGCCTGTCATGATGAC TCATCAGCTTCGGGGATGTGTT 160
SS3/O q ACCGCCAACACTGTCACCAAA ACTCGATGGAGCCCACAAACAC 374
SS4 q CTCCTGGAATGGACAGATCATCACC AAGCAAAGGGCTGTGTGAGGTACAG 189
β1 NM_019273 GTATCACACAGAAGACACTCGGGA AAGAAGGAGAAGAGGAGGATTTGGG 200
β2 NM_176861 ACTGGGAATCACACTGCTGCG ACTCACAAGGGACATGGACTCCTC 289
β3 XM_227040 CATCGCCATGATGGCCTCCT TCAGAGCGCCTCCCAGCAAT 485
β4 AB050637 ATGGCGAAGCTCAGGGTGTC ACTCGAACACCTCGCCGATC 202
ISH probes Antisense 5′–3′
SS2+174 NM_031828 AACATGCTCGGCTCATTCTCTTGTAGATGGGACA
SS4+81 AF135265 TTGACTGATACCAAAGGCAACTTGCCCGGCTTAGC
α-actin NM_031004 GCATAGAGGTCCTTCCTGATGTCAATATCACACTTC
CGRP M11597 TAAGGTTGACCTCAAAGGGACTGCCTGGAGGCCGCAT
PCR primers were designed to amplify transcript regions containing BK channel splice sites (SV1, X1, IsoC/X2, SS1, SS2, SS3/O and SS4), or BK β-subunits (β1–4). For in situ
hybridization (ISH) probes complementary to BK channel splice insert sequences (SS2+174 and SS4+81), α-actin and CGRP were designed. Accession number for template sequences
are shown together with the expected product size of insert-less variants (bp).
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mix along with primers. Reverse transcriptionwas carried out at 50 °C
for 30 min followed by a 15 minute heating step to 95 °C to inactivate
reverse transcription enzymes and to activate hot-start polymerase.
PCR temperature cycling was executed immediately hereafter
consisting of 30 to 33 one-minute cycles (denaturing at 94 °C,
annealing at 56 to 64 °C and extension at 72 °C). Cycling was followed
by a ﬁnal extension step at 72 °C for 10 min and cooling to 5 °C. PCR
reactionswere performed in 0.2ml tubes on a PTC-200 Peltier thermal
cycler (MJ Research). For each PCR run, a negative control without
template RNA was included (data not shown). PCR products were
analyzed on 2% agarose gels with ethidium-bromide staining (35 min
at 80 V) and photographed in an UV illumination box ﬁtted with a
digital camera. Gel images were black-white inverted and aligned
relative to a DNA ladder for illustration purpose.
2.4. Sequencing
PCR products to be sequenced were cut out of agarose gels guided
by UV-light, and puriﬁed with QIAquick® Gel Extraction Kit (QIAGEN).
In case the DNA yield was insufﬁcient for sequencing, the PCR product
was re-ampliﬁed with the same primers using diluted puriﬁed
product as template (1:20000). Air-dried samples were sequenced
by MWG Biotech (Martinsried, Germany) using the original sense or
anti-sense PCR primers as sequencing primers. Preferably, samples
from two ormore individual PCR reactions were sequenced in parallel.
2.5. In situ hybridization (ISH)
Oligonucleotide probes complementary to two rat BK channel
splice insert sequences (SS2+174, SS4+81), rat α-actin and calcitonin
gene related peptide (CGRP) were designed with Vector NTI and
ordered from MWG Biotech (Martinsried, Germany) (Table 2).
Oligonucleotides were 3′ labeled with 35S-ATP in a terminal
transferase reaction (Amersham) at 37 °C for 1 h. TE buffer (TRIS
10 mM, EDTA 1 mM) and yeast t-RNA (co-precipitant) was added and
the product was extracted in phenol/chloroform/isoamyl alcohol
(25:24:1), chloroform/isoamyl alcohol (49:1) and precipitated with
NaCl and ethanol at −20 °C. The pellet was washed in 80% ethanol, air
dried and re-dissolved in TE buffer with dithiothreitol (10 mM).
Parafﬁn embedded tissues were cut in sections (5 μm) and
mounted on Super Frost Plus glass slides. A cat's whisker placed
inside the lumen of arteries was used as guidance during section
cutting. Slides were immersed twice in toluene (5 min) to removeparafﬁn and rehydrated in a series of ethanol baths (99%, 96%, 70% and
30%) (3 min). Thenwashed in PBS (10 min), blocked in methanol with
hydrogen peroxide (1%) (20 min), and washed 3 times in PBS (5 min).
To reduce background, sections were acetylated for 10 min at room
temperature in saline (0.9% NaCl) with triethanolamine (0.1 M) and
acetic anhydride (0.25%) (pH 8.0). Then washed in PBS (10 min), SSC
(standard saline citrate) (10 min) and PBS (5 min). Finally, sections
were dehydrated in ethanol baths (70%, 96%, 99%, 99% and 99%) and
air-dried.
Sections were incubated overnight at 37 °C in humidity chamber
with 110 μl aliquots of SSC buffer containing labeled oligonucleotide
probe (1:100), formamide (45%), 1× Denhardts Solution (0.02% ﬁcoll,
polyvinylpyrrolidone and bovine serum albumin) (Sigma), ﬁsh sperm
DNA (0.5 mg/ml) (Roche), yeast tRNA (0.25 mg/ml), dextran sulfate
(10%) and DTT (10 mM). Negative controls were incubated with buffer
without probe. Sections were then brieﬂy washed in SSC followed by
two washes in SSC with 10 mM DTT (5 min), heated to 55 °C, washed
four times in SSC at 55 °C (15 min), twice in SSC (30 min) and twice in
deionizedwater (30min). Then air dried and dipped in a photographic
emulsion coating (Amersham, Denmark) at 42 °C and stored for
3 months at 4 °C in darkness. Afterwards, the slides were developed in
Amidol, ﬁxed in thiosulfate (30%), counterstained with Mayer's
heamatoxylin, dehydrated in ethanol baths (70%, 96%, 99%, 99% and
99%), washed twice in toluene (5 min) and ﬁnally mounted with cover
slips.
2.6. Cloning and expression in Xenopus laevis oocytes of BK splice
variants
An open reading frame of the rat BK channel was PCR ampliﬁed
from the conserved third initiation codon (MDALI) to upstream of the
C-terminal splice site 5 (ESRDKQstop) introducing an artiﬁcial stop-
codon. The ampliﬁcation was therefore independent on known N and
C-terminal variations [11,16]. PCR was performed with the Pfu Turbo
Cx polymerase (Stratagene) using uracil containing primers, which
allow unique 3′ overhangs to be generated though uracil excision [41]
(forward primer 5′GGCTTAAUATGGATGCGCTCATCATC, reverse primer
5′ GGTTTAAUTCACTGTTTGTCGCGGGACTC). The products were cloned
into the pNB1u vector optimized for expression in Xenopus laevis
oocytes and utilizing a USER cloning cassette [41]. Positive cloneswere
identiﬁed with PCR on single colonies and subsequent sequencing.
Messenger RNA was transcribed by in vitro transcription (T7
polymerase, New England Biolabs) from the cloned DNA template
and injected into Xenopus laevis oocytes. Activity of cloned BK
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upon stimulation with a step voltage protocol from −90 to +120 mV
from a −50 mV holding potential. See Supplementary material or
references for a thorough description of USER cloning [41] and
heterologous expression procedures [42].
3. Results
3.1. Identiﬁcation of potential splice sites
Initially, literature and databases were screened to identify known
splice variants of the BK channel α-subunit. The results are
summarized in Fig. 1 and Table 1. Most known sites for splice variation
observed in vertebrates were included in the study (Fig. 1, Table 1)
except from the sitemK44 [12], site H [11] andN- or C-terminal sites A,
B and SS5 [11,43]. Primer pairs were designed to span a single splice
junction except from the IsoC/X2 and SS3/O primers spanning two
sites (Fig. 1).
3.2 α-subunit isoforms
BK channel transcripts isolated from rat cerebral arteries,
meninges, trigeminal ganglion and brain were ampliﬁed with RT-PCR
and tested for the presence of splice variants by use of pairs of primers
spanning reported splice sites (see Fig.1 andTable 2), yielding alternate
sized RT-PCR products when insert sequences were present. For
comparisonof transcript levels a numberof other tissueswere analyzed
as well, all showing a profound BK channel expression (Fig. 2). Seven
different regions of the BK transcript were ampliﬁed with RT-PCR as
indicated by primer binding sites in Fig. 1, spanning nine known splice
sites (SV1, X1, IsoC, X2, SS1, SS2, SS3, O and SS4).
3.3. SS2
The SS2+174 variant containing a 174 bp insert at splice site two (SS2,
Fig. 1), also known as the STREX variant (Table 1), was present in small
amounts in most tissues compared to the short SS20 or “zero” form
(Fig. 2B). Highest levels were found in sagittal sinus and consistentFig. 1. Conceptual overview of previously reported sites for transcript variation in the verteb
peptide sequences, and binding sites for primers, used in the present study, indicated by a
topology (trans-membrane and intracellular segments S0–S10).signals were found in cerebral blood vessels (Fig. 2B) while less
expressed in brain and trigeminal ganglion. The identity of the longer
PCR-product insert was veriﬁed by sequencing of product from the
dura mater (Table 4). Also an intermediary form SS2+87 was found in
thoracic aorta and skeletal muscle (dominant form), with faint signals
in common carotid aorta and in heart atrium (Fig. 2B, Table 3).
Sequencing showed that this product (SS2+87) corresponds to an
alternative insert (e22, Table 1) at SS2 previously found in mice [13].
3.4. SS4
At splice site four (SS4), an additional PCR product clearly appeared
(SS4+81) in addition to the shortest transcript form (Fig. 2D). In the
trigeminal ganglion and the brain, the longer variant was the
dominating form, while it was present to some extent in pia mater,
most arteries and in skeletal muscle (Table 3). The longer transcript
found in the trigeminal ganglion,was identiﬁed (66 out of 81base-pairs
successfully sequenced) by sequencing as the Slo27 variant (Table 1)
previously found in rat brain [8,25]. Judged by product size and lack of
other known inserts, the longer transcripts found in other tissues at this
site, most likely contain the Slo27 insert.
3.5. IsoC, X2
The IsoC site of variation was identiﬁed by alignment of database
rat mRNA sequences, where the IsoC transcript (AY330292.1) contains
nine additional basepairs at the site. The X2 site has been found to
contain an insert sequence in rat cochlea [17].
The primer pair spanning the sites IsoC and X2, yielded a single
PCR product in most tissues except from a longer variant found in
superior sagittal sinus. Sequencing of this band showed a 92 bp insert
at the X2 site (X2+92⁎, Table 4) and no insert at IsoC. The odd number of
nucleotides induces a shift in reading frame and a stop codon within
the insert. Consequently, the resulting protein becomes truncated 14
amino acids downstream of the X2 splice sites (between the S6 and S7
segment) (Table 4). The insert was isolated from two different animals
and sequenced six times from individual PCR reactions with univocal
results.rate BK channel α-subunit. (A) Splice sites indicated by hyphens in the rat BK channel
rrows (not to scale). (B) Splice sites indicated by triangles relative to the ion channel
Fig. 2. RT-PCR results showing tissue distribution of transcript variants of rat BK α-subunits, at four different splice sites (SS1–4), using primer pairs amplifying regions of the
transcript including these splice sites. RT-PCR products were run on 2% agarose gels and gel images aligned relative to a DNAweight marker (numbers indicate base-pairs). Annealing
temperature and PCR cycle number are shown on the right together with the name of the primer-pair and the expected product-size of the shortest transcript variant. (A&C) No
apparent variation was found at splice site one (SS1) and three (SS3) where the shortest form was present only. (B) At splice site two (SS2), two longer forms appeared (SS2+87,
SS2+174) which were identiﬁed as two previously described 29 and 58 amino acid inserts (“e22” and “STREX”). The 29 amino acid insert was mostly found in thoracic aorta and in
skeletal muscle, while the 58 amino acid insert was widely expressed except from in aorta, kidney and skeletal muscle. (D) At splice site four (SS4) a longer form (SS4+81) identiﬁed as
a 27 amino acid insert (Slo27) was found to be dominant in brain and in trigeminal ganglionwith some expression in cerebral arteries, arteries and skeletal muscle as well. (E) At splice
site X1, a 24 bp longer transcript (X1+24) was found in the brain and trigeminal ganglion exclusively.
384 A.N. Poulsen et al. / Biochimica et Biophysica Acta 1788 (2009) 380–3893.6. X1
At the site X1, located in the extra-cellular loop between S1 and S2
in the protein [44], a 24 bp longer transcript variant (X1+24) was foundTable 3
Summary of α-subunit transcript variation and β-subunit expression observed with
RT-PCR
RT-PCR signals α-subunit splice variants β-subunits
Tissue X1+24 X2+92⁎ SS2+87 SS2+174 SS4+81 β1 β2 β3 β4
Pia mater − − − + + + + − +
Dura mater − − − (+) − + + − +
Middle cerebral artery − − − + + + + − +
Anterior cerebral artery − − − + + + + (+) +
Basilar artery − − − + (+) + + − +
Arterial circle of willis − − − + + + + − +
Superior sagittal sinus − + − + − (+) − − (+)
Common carotid artery − − (+) (+) + + − − +
Thoracic aorta − − + (+) + + − − +
Aorta − − − − − (+) (+) − +
Coronary artery − − − (+) − ++ (+) − +
Heart atrium − − (+) (+) (+) + ++ − ++
Heart ventricle − − − (+) − ++ ++ (+) ++
Brain + − − + ++ (+) ++ − ++
Trigeminal ganglion + − − + ++ (+) ++ − ++
Colon − − − + − + + − +
Uterus − − − (+) − + + − (+)
Bladder − − − (+) − + + − +
Lung − − − (+) − ++ ++ − ++
Kidney − − − − − + (+) − ++
Skeletal muscle − − ++ − + − + − −
Testis − − − + − + ++ + ++
−: No apparent signal. (+): Weak positive signal. +: Clear positive signal. ++: Strong
positive signal.in the brain and trigeminal ganglion exclusively (Fig. 2E) representing
an eight amino acid insert previously found in rat cochlea [44]. The
splice site is located between the second and third nucleotide in the
asparagine codon upstream of the insert (see Fig. 1). Asparagine is
therefore changed into lysine (see Table 3).
3.7. SV1, SS1, SS3, O
At splice sites SS1, SS3/O and SV1, a single PCR product appeared
(Figs. 2A, C and 3B) with a size corresponding to the shortest form of
the transcript at these sites (178, 374 and 171 bp respectively). The SV1
product was co-ampliﬁed with the β2 or β3 subunits (Fig. 3B, C). At
SV1, a 99 bp insert has been described in rat [21,45], at SS3 a 24 bp
insert have been observed in humans [10] and at O, a 123 bp insert
may be found in humans [11]. None of these were found in the tissuesTable 4
Translated sequences of the inserts identiﬁed at splice sites X1, X2, SS2 and SS4 (insert
sequences in italics)
Insert Sequence
X1+24 -SSK-SRTADSLI-PIE-TCA AA G AGC CGC ACA GCA GAC TCT TTG AT C CCA ATA
X2+92⁎ -AVSGRK-QCLPATCPKLLLSSstop -GCG GTT AGT GGA AGA AAG CAA TGT TTG
CCC GCTACGTGC CCG AAA TTG CTG CTC TCA TCC TGA ATC GGA ATA AAT TCG
GCG GGA CTT TTA ACA AAC ATG GAG GCA GAA AG CAC ATT-
SS2+87
“e2”
-RRL-KVEARARYHKDPFMHKNATPNSQHMPKPV-EDE-
SS2+174
“STREX”
-RRP-KMSIYKRMRRACCFDCGRSERDCSCMSGRVRGNVDTLERTFPLSSVSVNDCSTSFRAF-
EDE-
SS4+81
“Slo27”
-TEL-AKPGKLPLVSVNQEKNSGTHILMITEL-VND-
The nucleotide sequence is shown for the inserts found at X1 and X2 (underscored),
which at the X2 site induces a shift in reading frame and a stop-codon (TGA).
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40 amino acids have been described in humans and in turtles [10,24]
(Table 1). The two longer forms were not observed as seen on gels,
while the shortest form, potentially giving an increase in PCR product
size of merely 12 bps, cannot be easily excluded. Sequencing of the
product from middle cerebral artery showed that this was of the
shortest form (RESR-ILIN). The uniformity of product size and
equivalence with the product from middle cerebral artery, suggests
that the shortest form is dominating through-out the tissues
investigated.
3.8. β-subunits β1–4
The β1, β2 and the β4 subunits were expressed in cerebral vessels,
meninges, brain and trigeminal ganglion (Fig. 3, Table 3). The β1
showed a somewhat higher expression in blood vessels compared
with brain and trigeminal ganglion (Fig. 3A), while the β2 and β4
showed higher expression in brain, trigeminal ganglion and heart
compared to the cerebral arteries and meninges (Fig. 3B and D). Co-
ampliﬁcation (multiplex) of the α-subunit transcript served as
internal positive controls in these experiments.
An unexpected longer band appeared at 300–400 bp with the β2
primers (Fig. 3B). Sequencing identiﬁed this band as non-speciﬁc
ampliﬁcation of RAB3 GTPase-activating protein. The β3 subunit was
found expressed in testis only, except from very weak signals in the
anterior cerebral artery and heart ventricle (Fig. 3C, Table 3). A shorter
product at app. 250 bp, and a long product at app. 1000 bp, was found
as well in pia mater, brain and testis respectively (Fig. 3C). This could
be due to alternative splicing of the β3 subunits as the primer pair
spanned two splice junctions, yet the known splice variation of β3, is
generated at a splice-site outside (upstream) of the region covered by
the primer-pair [27]. The α-subunit primers used (SV1) generated no
extra bands of such sizes when tested alone (data not shown).Fig. 3. RT-PCR results showing expression of rat BK β-subunits (β1–4), co-ampliﬁedwith BKα
internal controls (IsoC/X2 or SV1), and to investigate the splice-compositions at these sites.
weight marker (numbers indicate base-pairs). Annealing temperature and PCR cycle number
the expected base-pair product-size. No additional longer bands appeared with the primers
novel 92 bp insert was found at the X2 site (X2+92⁎: Band between 450 and 500 bp in A and D
predominantly expressed in heart, nerve tissue, lung and testis, while absent in sagittal sinus
at app. 400 bp were a non-speciﬁc ampliﬁcation by the β2 primers of rat RAB3 GTPase-ac
additional bands of longer size seen in pia mater and brain (C).3.9. Localization of SS2+174 and SS4+81, by in situ hybridization
As RNA was isolated from crude tissue homogenates, the splice
variants SS2+174 and SS4+81 identiﬁed in cerebral vessels and
trigeminal ganglion with RT-PCR could originate from different cell
types within the tissue sample. To investigate the localization of the
splice variants, tissue sections of basilar and middle cerebral artery
and the trigeminal ganglion were hybridized with oligo-nucleotide
probes complementary to the splice variant sequences (Table 2).
Positive signals were observed within the arterial smooth muscle
layer (Fig. 4, TM) in basilar (BA) andmiddle cerebral arteries (MCA) for
both probes and consistent signals were seen in the trigeminal
ganglion (TGG) as well. Signal levels within tissue sections were
markedly higher than background levels on slides outside tissues and
in negative control tissues (Fig. 4). As positive controls, the basilar and
middle cerebral artery was hybridized with a probe against α-actin
and trigeminal ganglion with a probe against CGRP yielding strong
signals (Fig. 4). The ﬁnding of hybridization signals within smooth
muscle indicates that splice variants, identiﬁed with RT-PCR, are
indeed expressed in smooth muscle cells.
3.10. Activity of splice variants X1+24 and X2+92. Expression in Xenopus
oocytes
The splice variants of the vertebrate BK channel containing inserts
at splice X1 and X2 have until now only been identiﬁed on transcript
level by RT-PCR [17,44]. To investigate if these transcript variants
results in functional channels we cloned the coding sequences from
cDNA prepared from the middle cerebral artery or dura mater. An
open reading frame was chosen starting at the third known initiation
codon (MDALI) and ending an artiﬁcial stop codon (ESRDKQstop)
introduced upstream of the C-terminal splice site (SS5). By this,
ampliﬁcation was independent on potential N and C-terminal-transcript (multiplex PCR). Two different regions of theα-subunit were co-ampliﬁed as
RT-PCR products were run on 2% agarose gels and gel images aligned relative to a DNA
are shown on the right with name of the primer-pair, primer concentrations (in μM) and
spanning the splice sites IsoC/X2 (A) or SV1 (C), except from in sagittal sinus, where a
). β1 and β4 were found in most tissues except from skeletal muscle (A, D), and β2 was
, common carotid artery and thoracic aorta (bands at 300 bp in B). The longer bands in B
tivating protein. The β3 subunit was found expressed in testis only with some weak
Fig. 4. In situ hybridization showing expression of two BK channel splice variants in basilar artery (BA), middle cerebral artery (MCA) and trigeminal ganglion (TGG). Tissues sections
were hybridized with 35S-labeled oligonucleotide probes complementary to the splice inserts SS2+174 (STREX) and SS4+81 (Slo27). Positive signals (black dots exempliﬁed by arrows)
were found within the smoothmuscle layer (TM) in BA andMCA andwidespread in TGG for both probes. As positive controls (Pos.), BA andMCAwere hybridized againstα-actin, and
TGG against calcitonin gene-related peptide. Negative controls (Neg.) were incubated with buffer without probe. Magniﬁcation: BA and MCA ×63; TGG ×20. TM: tunica media. LEI:
lamina elastica interna.
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a vector optimized for expression in Xenopus oocytes. Clones were
obtained containing the X1+24 in combination with the SS4+81 insert
isolated from middle cerebral artery, or the X2+92 insert cloned from
the dura mater. The X1+24 variant without SS4+81 seems to be rare as
no clones were obtained containing this combination (out of 30–40
clones). Upon injection of in vitro transcribed mRNA into Xenopus
oocytes, we found expression of the X1+24 variant (combined with
SS4+81) (Fig. 5A,B), which showed a faster activation than the Zero
variant (observed as higher relative current level after capacitance
peak) (Fig. 5B) and a slight change in the voltage–current relation (Fig.
5C). The variant containing only the SS4+81 did not show the change in
activation speed (not shown). The X2+92 variant yielded no detectable
macroscopic current in oocytes indicating that the premature stop
codon and truncation after segment S6 hampers the formation of
functional channels. However, when co-expressed with the Zero
variant it appeared that X2+92 induces a slowing of activation
(lowered current level after capacitance peak, Fig. 5B) and as well a
change in the voltage–current relation (Fig. 5C) suggesting that the
X2+92 forms heteromeric complexes with the Zero subunits. Thus, theX1+24 (with SS4+81) variant is a functional channel while the X2+92 is a
silent but possibly modulatory BK variant.
4. Discussion
4.1. Multiple isoforms, possible co-expressions, novel truncated isoform
The ﬁnding of different splice variants (X1+24, X2+92, SS2+174 and
SS4+81) expressed in cerebral arteries, meninges, trigeminal ganglion
and brain in combination with the β-subunits β1, β2 and β4 reveals a
multitude of possible constellations of functional BK channels in these
tissues. It is known that the STREX (SS2+174) and Zero (SS20) splice
variants respond similarly or invertedly to co-expression with the β4
subunit at low versus high calcium concentrations [6], The interaction
of STREX with β1 and β2, which were found in cerebral vessels,
meninges and trigeminal ganglion, has not been investigated. Other
α- and β-subunit interactions that are functionally relevant are those
between the SS4+81 (Slo27) or X1+24 variants and β1, β2 and β4
subunits, which are expressed in brain and trigeminal ganglion. The
Slo27 variant is known to show a slightly altered Ca2+ response, but its
Fig. 5. Expression of BK splice variants in Xenopus oocytes. (A) Current recordings from oocytes expressing the variant containing the X1+24 insert (X1+24SS4+81), the insert-less
variant (Zero), or insert-less co-expressed with the X2+92 variant (Zero +X2+92). Membrane potential was clamped in steps to −90 to +120 mV for 400 ms from a holding potential of
−50 mV. (B) First 20 ms of upper current traces shown in A (+120 mV). The X1+24-containing variant channels apparently show faster current activation than the Zero variant as
indicated by current level after the capacitance peak (arrowheads). The X2+92 variant yields no detectable current when expressed alone (not shown) but appears to affect the
properties of the Zero variant when co-expressed. (C) Peak current levels from traces shown in A, plotted against step voltage, suggesting differences in the voltage-activation among
the Zero, X1+24SS4+81 and Zero +X2+92 variants.
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variant found in the superior sagittal sinus or dura mater may exert a
modulatory effect on other BK variants (Zero) while being a non-
functional ion channel itself. Obviously, this variant needs to be
studied further. The X2+92 insert sequence translates into 14 amino
acids followed by a stop codon (Table 3) resulting in a truncated
protein isoform lacking the intracellular segments S7 to S10. The
sequence can be found in an EST clone isolated from mouse retina
(100% similarity) (accession BB642344) [11]. Previous studies with
artiﬁcial truncated constructs has shown that such channel may show
little expression due to mis-trafﬁcking [46] or impaired tetrameri-
zation [47]. Yet, it has been argued that minute but signiﬁcant activity,
can be observed in Xenopus oocytes [48].
An insert very similar to X2+92 was previously found in rat cochlea
[17] (reported as peptide sequence only), which contains no stop
codon due to an additional single nucleotide in the ﬁrst codon in the
insert (93 instead of 92 basepairs). It would be a remarkable ﬁnding if
splice inserts differ among tissues on single nucleotide level.
The co-existence of multiple splice variants in most tissues raises
the question regarding dominant-recessive behavior as the BK
channel protein consists of a tetramer of α-subunits. The STREX
splice variant (SS2+174), which was found in several tissues, is known
to exert a dominant effect on BK channel characteristics when co-
expressed with the Zero (insert-less) isoform, inducing a reversal of
the ion channel response to cAMP (becomes inhibitory) [49]. It
appears that if just one of four α-subunits contains the STREX insert,
the whole channel phenotype is changed.4.2. Splicing pattern of the BK α-subunit
According to the predicted structure of the rat BK channel gene
(KCNMA1) on chromosome 15 (Celera assembly, NCBI Mapview,
Celera Genomics WGS), all splice sites identiﬁed so far represents
exon–exon boundaries except from the IsoC variant. The listed
potential IsoC variant (Table 1), which was not observed in this
study and found in a sequence database only, may be of minor
importance. The insert sequences X1+24, X2+92, SS2+87 and SS4+81 are
all retrieved from introns in between the splice site-ﬂanking exons
and constitutes only a small part of the intron. This indicates that the
splice variants are in fact generated by speciﬁc splicing of mRNA and
not due to biasing ampliﬁcation of genomic DNA or intermediately
spliced pre-mRNA. The SS2+87 insert sequence is placed in an intron
upstream of the SS2+174 (STREX) insert which is recognized by the
Celera assembly as an exon. The shortest form at splice site two is thus
generated by removal of the intron sequence and the adjacent
downstream exon. In contrast, the Reference assembly (RGSC, Human
Genome Sequencing Center, NCBI Mapview) of the rat BK gene shows
a conﬂicting exon structure with little congruence between known
splice sites, origin of splice variant insert sequences and predicted
exon–exon boundaries.
4.3. Differential expression of functional forms and pharmacotherapy
Pharmacological modulation of BK channels in artery smooth
muscle cells is a potential strategy for treating hypertension or vascular
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distribution of the channel. The functional diversity based on splice
variants and β-subunit co-expression is interesting due to the large
number of potential functional forms, which may have different
physiological roles and a differentiated tissue expression pattern.
Regarding pharmacology, the β-subunits are interesting in that β1
and β2 reduces charybdotoxin sensitivity [50,51] and is necessary for
the activation of BK by DHS-1 [14,51], while β4 renders the channel
insensitive to iberiotoxin and charybdotoxin [15]. On the other hand,
very little is known about the pharmacology of the α-subunit splice
variants. A study has shown a difference in the response to
amphipaths (membrane modulating agents) relating to the presence
of the STREX exon [18].
4.4. Potential implication for headache
When comparing the cerebral arteries and the trigeminal ganglion,
both tissues contain BK channels, but they vary greatly in their content
of the SS4+81 and X1+24 variants which were found mostly in the
nerve. The β2 and β4 showed a somewhat stronger expression in the
nerve, while β1 was more expressed in the cerebral arteries. These
ﬁndings may be of interest for the development of pharmacological
strategies against migraine headache, which is a neuro-vascular
disorder involving cerebral vasodilation and activation of nociceptive
trigeminal nerves. Selective targeting of BK channels in either of these
tissues may be of value as treatment. An inhibition of smooth muscle
BK channels would precipitate increased vascular constriction, which
is known to give acute relief during migraine, while modulation of BK
channels in the nerve may affect excitability.
Although the impact of the newly identiﬁed X2+92 BK variant
found in dural tissue is not known, this variant may be of particular
therapeutic interest as it showed a highly restricted expression.
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